Journal article
Drug targeting in cancer therapy
Open Schools Journal for Open Science, Vol.3(2)
2020
Abstract
Drug targeting enables the local release of medication at the desired site or organ. This ensures that the drug asserts its effects focused to a small site, minimising systematic side effects. Drug targeting has been successfully applied in cancer therapy and can be performed actively or passively. During passive drug targeting, carriers containing the active cancer drug concentrate within the tumour tissue due to increased blood circulation and vascular permeation (enhanced penetration retention principle). Active drug targeting on the other hand, facilitates ligand-receptor interactions.
Details
- Title
- Drug targeting in cancer therapy
- Authors/Creators
- L. Nys (Author/Creator) - Barmherzige Schwestern vom heiligen KreuzP. Raeuschl (Author/Creator) - Gymnasium der KreuzschwetsternI.A. Joubert (Author/Creator) - University of SalzburgM. Geppert (Author/Creator)S. Ess (Author/Creator) - University of SalzburgM. Himly (Author/Creator) - Biowissenschaften
- Publication Details
- Open Schools Journal for Open Science, Vol.3(2)
- Publisher
- E-Publishing
- Identifiers
- 991005541235007891
- Copyright
- © 2020 The Authors.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
- Additional Information
- Abstract of poster presented orally in the moderated poster session at the International Open NanoScience Congress, 26.2.2019, Salzburg
Metrics
13 File views/ downloads
36 Record Views